Show Notes
Host Scott Draeger welcomes Optum Rx Vice President of Trend Insights & Analytics Michelle Kamprath and Optum Rx Senior Director of Drug Pipeline & Surveillance Bill Dreitlein for a lively discussion of the year ahead in pharmacy. Find out which trends are expected to make noise in 2024 including the ongoing obesity drug dilemma facing plan sponsors, the impact of the profusion of biosimilars on drug costs, and some noteworthy drug candidates currently advancing through the pipeline.
More from Pharmacy Insights Podcast
Transparency in pharmacy benefits is essential to helping employers better make more informed decisions for their plans and the people they serve. In the latest episode of the Optum Rx Pharmacy Insights Podcast, Sarah King, President of our Employer Services Division at Optum Rx and Tracy Spencer, Senior Vice President of Strategy at Optum Rx examine how true transparency is more than just a buzzword.
Guests: Ryan Perkins, VP Artificial Intelligence Capabilities at Optum, and Sarah Greenwell, Sr. Director Digital Product at Optum Rx
The speed at which the use of advanced technologies such as Artificial Intelligence are reshaping pharmacy benefits is only increasing. As we look at 2026, what are the most impactful changes for plan sponsors and members? Host Scott Draeger welcomes guests Optum Rx Senior Vice President Enterprise Capabilities Jen McGonigle and Optum Rx Chief Information Officer Santiago Abraham to learn about the latest developments.
The use of artificial intelligence has exploded into the public consciousness in recent years. While people are becoming more accustomed to the presence of AI in their personal lives, what does it mean for pharmacy care services? On the latest episode of the Pharmacy Insights Podcast, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Santiago Abraham, Chief Information Officer at Optum Rx and Sid Sahni, Senior Vice President of Strategy and Innovation at Optum Rx to discuss how Optum Rx is approaching the use of AI and what that means for sponsors and users of pharmacy benefits.
The array of challenges faced by sponsors of the pharmacy benefit are constantly evolving. To help plan sponsors get a sense of the emerging options available to help them, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Mike McGinnity, Senior Vice President of Growth and Retention at Optum Rx and Sid Sahni, Senior Vice President of Strategy and Innovation at Optum Rx to discuss the current state of innovation in pharmacy care services on the latest episode of the Pharmacy Insights Podcast.